Impact of a community-based participatory research project with underserved communities at risk for hepatitis C virus in Ho Chi Minh City, Vietnam: an evaluation study by Thao, MNL, Quoc, GN, An, MDT, Minh, HN, Hong, SP, Thai, AH, Thi, PT, Thanh, VNT, Thi, NT, Minh, TN, Flower, B, Cooke, GS, Chambers, M, Van Nuil, JI

The direct-medical costs associated with interferon-based treatment for hepatitis C in Vietnam by Nguyen, HA, Cooke, GS, Day, JN, Flower, B, Phuong, LT, Hung, TM, Dung, NT, Khoa, DB, Hung, LM, Kestelyn, E, Thwaites, GE, Chau, NVV, SEARCH Investigators, Turner, HC

Efficacy of ultra-short, response-guided sofosbuvir and daclatasvir therapy for hepatitis C in a single-arm mechanistic pilot study by Flower, B, Hung, LM, Mccabe, L, Ansari, MA, Hoglund, RM, Tarning, J, Kestelyn, E, van Doorn, R, Van Nuil, JI, Thwaites, GE, Barnes, E, Rahman, M, Walker, AS, Day, JN

Prevalence of antibody positivity to SARS-CoV-2 following the first peak of infection in England: serial cross-sectional studies of 365,000 adults by Ward, H, Cooke, GS, Atchison, C, Whitaker, M, Elliott, J, Moshe, M, Browne, JC, Flower, B, Daunt, A, Ainslie, K, Ashby, D, Donnelly, CA, Riley, S, Darzi, A, Barclay, W, Elliott, P

Rise in alanine aminotransferase after HCV treatment is a highly sensitive screen for treatment failure by Flower, B, Nguyen Thi Ngoc, P, McCabe, L, Le Ngoc, C, Vo Thi, T, Thi Kim, HV, Dang Trong, T, Rahman, M, Thwaites, G, Walker, AS, Hung, LM, Vinh Chau, NV, Cooke, GS, Day, JN

A new combination testing methodology to identify accurate and economical point-of-care testing strategies by Jain, S, Jónasson, JO, Pauphilet, J, Flower, B, Moshe, M, Fontana, G, Satkunarajah, S, Tedder, R, McClure, M, Ashrafian, H, Elliott, P, Barclay, WS, Atchison, C, Ward, H, Cooke, G, Darzi, A, Ramdas, K

High cure rates for HCV genotype 6 in advanced liver fibrosis with 12 weeks sofosbuvir and daclatasvir: The Vietnam SEARCH Study by Flower, B, McCabe, L, Ngoc, CL, Hung, LM, Phuong, LT, Trong, TD, Thi, TV, Kim, HVT, Tat, TN, Hong, DPT, Chau, ANT, Thi, TD, Tuyet, NTT, Tarning, J, Kingsley, C, Kestelyn, E, Pett, SL, Thwaites, G, Chau, NVV, Smith, D, Barnes, E, Ansair, A, Turner, H, Rahman, M, Walker, AS, Day, J, Cooke, GS

Treatment options to support the elimination of Hepatitis C: an open label, factorial randomised controlled trial by Cooke, G, Le Manh, H, Flower, B, McCabe, L, Vu Thu Kim, H, Vo Thi, T, Dang Trong, T, Nguyen Thanh, D, Le Thanh, P, Dao Bach, K, Nguyen Thi Chau, A, Pham Ngoc, T, Vu Thu Thu, H, Dang Thi, B, Nguyen Kim, T, Ansari, A, Le Ngoc, C, Vo Minh, Q, Nguyen Thi Ngoc, P, Le Thi, T, Nguyen Bao, T, Kestelyn, E, Kingsley, C, Van Doorn, R, Rahman, M, Pett, S, Thwaites, G, Barnes, E, Day, J, Nguyen Van Vinh, C, Walker, AS

Development and internal validation of clinical prediction models for outcomes of complicated intra-abdominal infection by Ahmed, S, Bonnett, L, Melhuish, A, Adil, MT, Aggarwal, I, Ali, W, Bennett, J, Boldock, E, Burns, FA, Czarniak, E, Dennis, R, Flower, B, Fok, R, Goodman, AL, Halai, S, Hanna, T, Hashem, M, Hodgson, SH, Hughes, G, Hurndall, K-H, Hyland, R, Iqbal, MR, Jarchow-MacDonald, A, Kailavasan, M, Klimovskij, M, Laliotis, A, Lambourne, J, Lawday, S, Lee, F, Lindsey, B, Lund, JN, Mabayoje, DA, Malik, KI, Muir, A, Narula, HS, Ofor, U, Parsons, H, Pavelle, T, Prescott, K, Rajgopal, A, Roy, I, Sagar, J, Scarborough, C, Shaikh, S, Smart, CJ, Snape, S, Tabaqchali, MA, Tennakoon, A, Tilley, R, Vink, E